CONTI, Giorgio
 Distribuzione geografica
Continente #
NA - Nord America 3.358
AS - Asia 2.703
EU - Europa 1.909
SA - Sud America 299
AF - Africa 121
Continente sconosciuto - Info sul continente non disponibili 17
OC - Oceania 2
Totale 8.409
Nazione #
US - Stati Uniti d'America 3.243
SG - Singapore 1.149
CN - Cina 651
VN - Vietnam 360
IE - Irlanda 345
DE - Germania 310
FI - Finlandia 296
SE - Svezia 268
BR - Brasile 223
HK - Hong Kong 189
UA - Ucraina 188
TR - Turchia 133
IT - Italia 125
ZA - Sudafrica 89
NL - Olanda 84
CA - Canada 80
FR - Francia 76
GB - Regno Unito 69
BD - Bangladesh 58
AT - Austria 38
RU - Federazione Russa 38
AR - Argentina 31
JP - Giappone 26
IN - India 25
IQ - Iraq 21
BE - Belgio 20
MX - Messico 16
PL - Polonia 16
EC - Ecuador 13
UZ - Uzbekistan 12
ES - Italia 10
PH - Filippine 10
CO - Colombia 8
VE - Venezuela 8
AE - Emirati Arabi Uniti 7
EG - Egitto 7
KR - Corea 7
CL - Cile 6
ID - Indonesia 6
JM - Giamaica 6
PY - Paraguay 6
RO - Romania 6
TH - Thailandia 6
LT - Lituania 5
NP - Nepal 5
PK - Pakistan 5
SA - Arabia Saudita 5
TN - Tunisia 5
AZ - Azerbaigian 4
EU - Europa 4
KE - Kenya 4
AO - Angola 3
BG - Bulgaria 3
ET - Etiopia 3
JO - Giordania 3
MA - Marocco 3
TT - Trinidad e Tobago 3
TW - Taiwan 3
AU - Australia 2
BB - Barbados 2
BH - Bahrain 2
CZ - Repubblica Ceca 2
GE - Georgia 2
KZ - Kazakistan 2
LU - Lussemburgo 2
OM - Oman 2
PS - Palestinian Territory 2
PT - Portogallo 2
SC - Seychelles 2
SN - Senegal 2
AL - Albania 1
BO - Bolivia 1
BY - Bielorussia 1
CI - Costa d'Avorio 1
CR - Costa Rica 1
DK - Danimarca 1
DZ - Algeria 1
GD - Grenada 1
GT - Guatemala 1
GY - Guiana 1
HU - Ungheria 1
IL - Israele 1
IR - Iran 1
LB - Libano 1
LK - Sri Lanka 1
MY - Malesia 1
NG - Nigeria 1
NI - Nicaragua 1
NO - Norvegia 1
PA - Panama 1
PE - Perù 1
PR - Porto Rico 1
QA - Qatar 1
SK - Slovacchia (Repubblica Slovacca) 1
SV - El Salvador 1
TM - Turkmenistan 1
UY - Uruguay 1
VG - Isole Vergini Britanniche 1
YE - Yemen 1
Totale 8.396
Città #
Singapore 605
Chandler 415
Dublin 345
San Jose 317
Ashburn 315
Jacksonville 302
Santa Clara 251
Hong Kong 184
Beijing 159
Dearborn 158
Izmir 119
Ho Chi Minh City 114
Council Bluffs 101
Munich 100
Boardman 96
Dallas 93
Johannesburg 85
Nanjing 80
Hanoi 79
Ann Arbor 78
San Mateo 72
Princeton 70
Helsinki 66
Lauterbourg 58
Toronto 49
Los Angeles 48
Shanghai 48
Wilmington 48
New York 46
Vienna 38
Bremen 36
Columbus 29
Moscow 28
Nanchang 26
Parma 26
Hebei 25
São Paulo 22
Tokyo 21
Brussels 20
Des Moines 20
Jiaxing 20
Haiphong 19
Jinan 19
Shenyang 19
Buffalo 17
Da Nang 16
Kunming 15
Denver 14
Tianjin 14
Turku 14
Hefei 13
London 13
Montreal 13
Seattle 13
Warsaw 13
Frankfurt am Main 11
Brooklyn 10
Houston 10
The Dalles 10
Woodbridge 10
Baghdad 9
Changsha 9
Chicago 8
Norwalk 8
Rome 8
Tashkent 8
Trezzano Sul Naviglio 8
Atlanta 7
Brasília 7
Coventry 7
Phoenix 7
Salvador 7
San Francisco 7
Biên Hòa 6
Can Tho 6
Chennai 6
Mestre 6
Orem 6
Ottawa 6
Grafing 5
Guayaquil 5
Londrina 5
Milan 5
Quito 5
Stockholm 5
Taiyuan 5
Tappahannock 5
Auburn Hills 4
Belo Horizonte 4
Bogotá 4
Bologna 4
Boston 4
Düsseldorf 4
Falls Church 4
Hải Dương 4
La Plata 4
Nairobi 4
Nova Iguaçu 4
Poplar 4
Quận Ba 4
Totale 5.303
Nome #
Activity of a synthetic microbicidal peptide against Influenza A virus multiplication 246
Inhibition of human and avian type A Influenza virus multiplication by NEK-2 treatment 204
Antibodies as a source of anti-infective peptides: an update 195
Abortive replication of influenza A viruses in HeLa 229 cells 189
Activity of a synthetic microbicidal peptide against Influenza A virus multiplication 177
Detection of IgA and IgM antibodies to HIV-1 in neonates by radioimmune western blotting. 177
Inhibition by prostaglandin PGA1 on the multiplication of influenza virus is a dose-dependent effect 163
Great reduction of human and avian type A Influenza virus multiplication by MESNA ( sodium-2 mercaptoethanesulfonate ) treatment. 158
Peptides from the inside of the antibodies are active against infectious agents and tumours 157
Antibodies as unlimited source of anti-infective, anti-tumor and immunomodulatory peptides 156
Defective insertion of haemagglutinin as a cause of abortivity of influenza A viruses in HeLa 229 cells. 151
Therapeutic Activity of an Anti-Idiotypic Antibody-Derived Killer Peptide against Influenza A Virus Experimental Infection 143
Effect of coumermycin on influenza A virus replicative cycle. 139
Different patterns of replication in influenza virus-infected KB cells 133
Determinazione di anticorpi anti-HIVmediante un sistema modificato di immunoblotting 130
Attività terapeutica di un peptide sintetico killer nei confronti di virus influenzali 130
Improved immunoblotting for the detection and quantitative analysis of antibodies to human immunodeficiency virus. 129
Biological characterization of FPV, Ulster 73, replicative cycle. 128
Inhibition of multiplication of RNA genome-containing viruses performed by differentconcentrations ofMESNA 127
Inhibition of late influenza virus genome expression by diamidinophenylindole. 126
Attività terapeutica di un peptide sintetico killer nei confronti di virus influenzali aviari ed umani. 124
Aspetti epidemiologici delle batteriemie in Italia: osservazioni effettuate presso il Laboratorio di Microbiologia di Parma 124
Batteriemie da germi anaerobi 124
Chromomycin A3 inhibits influenza a virus multiplication in chick embryo fibroblast cells 124
Control of influenza virus polypeptide synthesis 124
Restriction of Influenza virus multiplication induced by PK peptide treatment 123
The use of radioimmune western blotting to evaluate indeterminate western blotting results in blood donor HIV serodiagnosis 122
Different patterns of replication in influenza virus-infected KB cells 122
Cerulenin inhibits production of mature virion particles in chick embryo fibroblasts infected by influenza A viruses. 121
Migration of influenza virus-specific polypeptides from cytoplasm to nucleus of infected cells. 121
Inhibition of human and avian type A Influenza virus multiplication performed by MESNA 121
CERULENIN INHIBITS THE PRODUCTION OF MATURE VIRION PARTICLES IN CHICK EMBRYO FIBROBLASTS INFECTED BY INFLUENZA A VIRUSES 117
Inhibition performed by a synthetic microbicidal peptide on the replication of Influenza virus. Abstract 21.009 116
Radioimmune western blotting in comparison with conventional western blotting, second and third generation ELISA assays for the serodiagnosis of HIV-1 infection. 116
THE USE OF SODIUM 2-MERCAPTOETHANESULFONATE AS ANTIVIRAL AGENT Description not available for EP1596851 (A1) Description of corresponding document: WO2004069235 (A1) 116
Inibizione della replicazione di virus influenzali mediante trattamento di cellule infette con un peptide sintetico killer 115
Inhibition of multiplication of RNA genome containing viruses performed by different concentrations of MESNA. 114
USE OF SODIUM 2-MERCAPTOETHANESULFONATE AS ANTIVIRAL AGENT. 113
Physical characterization of N4-coded messenger RNA 113
Effetto di PGA1 e PGJ2 sulla replicazione del virus influenzale 113
Great reduction of human and avian type A Influenza virus multiplication by MESNA ( sodium-2 mercaptoethanesulfonate ) treatment 110
Inhibition of multiplication of RNA genome containing viruses performed by different concentrations of MESNA. 110
Inibizione della migrazione della emoagglutinina HA del virus Ulster 73 indotta dalla prostaglandina PGA1 109
Restriction of A/WSN/33 influenza virus multiplication by prostaglandin PGJ2 109
Inhibition of production of Influenza A viral particles induced by PGA1 treatment 108
Spettro d'azione universale di mimotopi killer antifungini 106
Modification of cytoskeleton and prosome networks in relation to protein synthesis in influenza A virus-infected LLC-MK2 cells 105
ABORTIVE REPLICATION OF INFLUENZA A VIRUSES IN HELA 229 CELLS 104
Indagine epidemiologica dei microrganismi responsabili di infezioni nosocomiali caratterizzate da batteriemie e/o fungiemie 102
RIWB in comparison with conventional WB, second and third generation ELISA assays for the serodiagnosis of HIV infection 101
Macromolecular synthesis during abortive infection of KB cells by influenza virus 100
Phosphorylation of viral polypeptides in cells infected with influenza virus 99
GREAT REDUCTION OF HUMAN AND AVIAN TYPE A INFLUENZA VIRUS MULTIPLICATION BYMELITTIN TREATMENT 99
ROLE OF ACYLATION OF VIRAL HAEMAGGLUTININ DURING THE INFLUNZA VIRUS INFECTIOUS CYCLE 98
Sepsi da catetere venoso centrale in corso di insufficienza renale. Aspetti epidemiologici e clinici. 98
Inibizione della migrazione della emoagglutininaHA del virus influenzale umano WSN/33,H1N1,indotta dalla prostaglandina PGJ2 96
Role of acylation of viral haemagglutinin during the influenza virus infectious cycle 95
Inibizione della moltiplicazione del virus influenzale umano WSN/33,H1N1,indotta dalla prostaglandina PGA1:effetto dose-dipendente 95
INHIBITION OF HUMAN AND AVIAN TYPE A INFLUENZA VIRUS MULTIPLICATION PERFORMED BY MESNA. 94
THE USE OF SODIUM 2-MERCAPTOETHANESULFONATE AS ANTIVIRAL AGENT 94
Inhibitory effect of diamidinophenylindole on the replication of influena virus in permissive cellular host. 93
Restriction of Influenza virus multiplication induced by treatment with a yeast killer toxin-like synthetic peptide 91
Viral protein synthesis during replication of bacteriophage T1. 91
THE USE OF SODIUM 2-MERCAPTOETHANESULFONATE AS ANTIVIRAL AGENT. 85
Therapeutic Activity of an Anti Idiotypic Antibody-Derived Killer Peptide against Influenza A Virus Experimental Infection 84
Radio immune Western blotting: a possible solution to indeterminate conventional Western blotting results for the serodiagnosis of HIV infections. 83
INHIBITION OF LATE INFLUENZA VIRUS GENOME EXPRESSION BY DIAMIDINEPHENILINDOLE 80
Inhibition of multiplication of RNA genome- containing viruses performed by different concentrations of MESNA. 80
Synthesis of stable RNA in "Escherichia coli" cells infected with N4. 80
Il significato delle colture intraoperatorie della parete e del trombo negli interventi per aneurisma dell'aorta addominale 69
Totale 8.409
Categoria #
all - tutte 28.064
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 28.064


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2021/2022335 0 3 2 17 18 11 48 56 20 36 24 100
2022/20231.389 130 129 77 131 136 180 4 95 458 7 26 16
2023/2024339 22 37 5 8 34 76 31 26 12 8 33 47
2024/20251.570 17 83 89 71 160 255 60 65 219 112 127 312
2025/20262.822 249 228 321 235 438 201 378 70 364 161 114 63
2026/2027155 40 115 0 0 0 0 0 0 0 0 0 0
Totale 8.409